XM does not provide services to residents of the United States of America.
P
P

Paypal

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

U.S. STOCKS CC Holding, CBRE, Lexicon Pharmaceuticals

BUZZ-U.S. STOCKS ON THE MOVE-CC Holding, CBRE, Lexicon Pharmaceuticals Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Dow hovered at levels seen more than a week ago on Friday, as investors took comfort from data pointing to robust economic activity in the world's biggest economy.
F
I
N
P
R
U
U
H

U.S. STOCKS Jet.AI, SL Green, WTW

BUZZ-U.S. STOCKS ON THE MOVE-Jet.AI, SL Green, WTW Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Dow touched over one-week highs on Friday after data showed a still robust economy, while small-cap stocks outperformed large-cap indexes.
F
I
N
P
R
U
U
H

U.S. STOCKS Tapestry, Eyenovia, Viking Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Tapestry, Eyenovia, Viking Therapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures slipped on Friday as investors remained cautious ahead of a business activity survey and increasing geopolitical tensions between Ukraine and Russia, but Wall Street's main indexes were poised for weekly gains.
A
B
I
N
P
R

Piper Sandler assumes coverage of Paypal with 'neutral' rating

BUZZ-Piper Sandler assumes coverage of Paypal with 'neutral' rating ** Piper Sandler assumes coverage of Paypal PYPL.O with "neutral" rating ** Brokerage says management team is focused on shifting PYPL to full-fledged commerce platform ** Expects co's revenue growth to be 6.5% in FY24 and 6.1% in FY25 ** Piper Sandler sets PT at $88, a ~3.7% upsid
P

U.S. CPI Card Group, First Solar, Viking Therapeutics

U.S. RESEARCH ROUNDUP- CPI Card Group, First Solar, Viking Therapeutics Nov 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CPI Card Group, First Solar and Viking Therapeutics, on Friday. HIGHLIGHTS * BJ's Wholesale Club Holdings Inc BJ.N : TD Cowen raises target price to $110 from $95 * CPI Card Group PMTS.O : D.A.
I
N
N
P
F
R
G
A
F
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.